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Synopsis 
 A key variant, rs3392713, in the sodium-dependent vitamin C transporter protein gene 
SCLA23A1 was associated with age-related cortical cataract. There was no association with 
cataracts in the nuclear or post-subcapsular region of the lens.  
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Abstract  
Background: Cataract is a major health burden in many countries and a significant problem 
in India. While observational studies show lower cataract risk with increasing dietary or 
plasma vitamin C, randomized controlled trials of supplements have been negative. Genetic 
variants in vitamin C transporter proteins (SLC23A1), especially rs3392713, may provide 
evidence o  a causal association of vitamin C with cataract.  
Methods: We used data from a randomly-selected population-based study in people aged 60 
years and over in north and south India.  Of 7518 sampled, 5428 (72%) were interviewed for 
socioeconomic and lifestyle factors, attended hospital for lens imaging and blood collection 
and were subsequently genotyped for rs3392713 and rs6596473. Mixed or pure types of 
cataract were graded by the Lens Opacity Classification System III as nuclear (2404), cortical 
(494) or posterior subcapsular cataract (PSC) (1026); 1,462 had no significant cataract and no 
history of cataract surgery and 775 had bilateral aphakia/ pseudophakia.  
Results:  rs3392713 was associated with cortical (OR=2.16, 95% Confidence Interval, 1.34, 
3.49, p=0.002) and PSC, OR=1.68 (1.06, 2.65, p=0.03) but not with nuclear cataract. In 
analyses of pure cataracts, associations were found only between rs3392713 and pure cortical 
cataracts, OR= 2.29 (1.12, 4.65) p=0.03 and with a standardized cortical opacity score. There 
was no association with rs6596473 and any cataract outcomes. 
Conclusions:  Using an established genetic variant as a proxy for lifetime ascorbate 
concentrations, our results support a causal association of vitamin C with cataract.  
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Introduction 
Evidence from in vitro and animal studies strongly supports a role for vitamin C (ascorbate) 
in lens protection.
1
  While observational studies generally show that cataract risk is reduced 
with increasing dietary vitamin C intake or blood ascorbate concentration, randomized 
controlled trials (RCT) of supplements have not been confirmatory.
2
 These studies have been 
conducted mainly in  high-income populations with adequate dietary intakes of vitamin C and 
plasma ascorbate concentrations.  In two population-based studies in India with low ascorbate 
concentrations, we also found plasma ascorbate was inversely associated with cataract. 
3 4
  
These studies were cross- sectional and associations might reflect reverse causation or 
confounding by poverty-associated factors.  A RCT in a rural population in India found no  
benefit  in the  progression of opacities over a 5-year period from supplementation with  high 
dose vitamins A, C, and E.
5
 The lack of  convincing evidence from this and other RCTs  is 
not surprising since a priori it is unlikely that vitamin supplements given for a relatively short 
duration would prevent an age-related disease. Genetic variants in sodium-dependent vitamin 
C transporter proteins (SVCTs), SLC23A1 and SLC23A2 
6
  are not subject to these concerns 
and can  provide stronger evidence on the unconfounded association of ascorbate with 
cataract (Mendelian Randomization, MR).  In particular, variant rs3392713 (SLC23A1) has 
demonstrated large effects on ascorbate concentrations and is considered a marker of lifelong 
ascorbate levels suitable for MR studies.
7 8
 In a small study of  60 patients undergoing 
cataract surgery in India we reported that SLC23A1 (rs6596473) and SLC23A2 (rs12479919, 
rs1279683) variants influenced plasma, aqueous and lens ascorbate concentrations.
9
 Since it 
is not possible to conduct similar investigations of ascorbate concentrations in the aqueous 
and lens of people without cataract, no conclusions can be drawn on whether these variants 
are associated with cataract risk. We report the results of an investigation using data already 
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collected in the population-based cross-sectional study, India age-related eye disease study 
(INDEYE.  
 
Methods 
INDEYE Study population  
The aims of the INDEYE study were to investigate the prevalence and risk factors for age-
related macular degeneration and cataract. The study sampling has been described.
10
  In brief, 
people aged 60 and over were identified from household enumeration of randomly sampled 
villages and small towns in Haryana state ( north India centre) and Tamil Nadu (south India 
centre),  served by the participating eye hospitals (Dr Rajendra Prasad Center of Ophthalmic 
Sciences, (RPC), Delhi and the Aravind Eye Hospital (AEH), Pondicherry). All enumerated 
people aged 60 and over were invited to take part.  
Ethics Statement 
Participants gave full informed written consent. Illiterate subjects had the information leaflet 
read to them and provided a thumb impression. The study complied with the Declaration of 
Helsinki guidelines. Ethics approval was received from the Indian Council for Medical 
Research, Research Ethics Committees of the All India Institute of Medical Sciences, 
Aravind Eye Hospital, London School of Hygiene and Tropical Medicine and Queen’s 
University Belfast.  
INDEYE Study Methods 
Data collection took place between September 2004 and December 2006. Enumerators 
collected household and individual socio-demographic and economic data. Fieldworkers 
interviewed participants at home with a structured questionnaire which included tobacco and 
alcohol use, current and past outdoor work and duration and type of cooking fuels. Diet was 
assessed by 24- hour recall. Within a week of the interview participants attended the base 
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hospital for the clinical examination which included anthropometry (height, weight, and mid-
upper arm circumference, MUAC), blood pressure, an eye examination and blood sample 
collection.   
Assessment of cataract 
Following pupillary dilatation to at least 6 mm, digital slit beam images were taken according 
to a standardized protocol using the Topcon SL-D7 Digital photo slit lamp for nuclear 
opacities (Topcon, Tokyo, Japan). Retroillumination images of the lens (one focused on the 
anterior and one focused on the posterior capsule) were taken with the Neitz CT-S digital 
camera (Kowa Optimal Inc., Torrance, California) to capture cortical and PSC. Lens opacities 
were graded according to the Lens Opacities Classification System III (LOCS III)
11
 in 0.1 
unit steps for each opacity up to a maximum of 6.9 for nuclear opacities, and 5.9 for cortical 
and PSC. The training and quality assurance of the photographers and graders have been 
described.
10
 We categorized the type of unoperated cataract based on the LOCS III grade in 
the worse eye of: ≥4 for nuclear cataract, ≥3 for cortical cataract and ≥2 for PSC. The 
comparator group were those with no cataract (i.e. opacity score of: <4 nuclear and <3 
cortical and <2 PSC, no dense opacities and no aphakia/pseudophakia). We chose these cut 
points to have high sensitivity for visually-significant cataract and a marker of the severity of 
lens opalescence.  The prevalence of cataract and cataract types has been published 
previously.
10
  
Blood sample 
Full details have been provided.
4
 For  plasma ascorbate, we collected an EDTA blood sample 
which was centrifuged at 4
0 
C, stabilized with metaphosphoric acid, aliquoted and transferred 
to a -70°C freezer. Samples were shipped in dry ice to Queen’s University Belfast for 
analysis and stored at -80°C. Ascorbate was measured by automated fluorometric assay on a 
Cobas FARA centrifugal analyzer (Roche Diagnostics, Switzerland). The limit of detection 
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of the assay was 2 µmol/L. Assays were standardized against the US National Institute of 
Standards and Technology standard reference materials.  We collected a non-fasting sample 
of capillary blood which was assessed for glucose using a reagent strip test and reflectance 
meter. Buffy coats were stored at -80°C at Aravind Medical Research Foundation, Madurai 
until DNA extraction between 2008 and 2009. Genomic DNA was extracted from peripheral 
blood leukocytes using Quiagen kits. 
 
Methods for present study 
Genotyping 
Genotyping was undertaken at Aravind Medical Research Foundation  using a TaqMan assay 
in an ABI (Applied Biosystems) 7900 HT Fast Real-Time PCR system. We genotyped 
rs33972313 in SLC23A1 as the primary Single Nucleotide Polymorphism (SNP) of interest. 
We also genotyped SLC23A1 SNPs rs42577623, rs6596473, rs10063949  and one SLC23A2 
SNP (rs12479919) which we previously showed influenced lens nucleus ascorbate.
9
  Details 
of  the SNPs are provided in Supplementary Table 1.  
We repeated genotyping for SLC23A2 rs12479919 since 6% of calls were undetermined but 
despite a high call rate the SNP failed Hardy Weinberg Equilibrium (HWE) (p=0.004) and is 
not discussed further. rs42577623, rs6596473 and rs10063949 were in high Linkage 
Disequilibrium, (LD) r
2
 =0.89 to 0.93 and we show results for rs6596473 only.  
 
Statistical analysis 
Statistical analysis was carried out using Stata version 14 (Stata Statistical Software: Release 
14. College Station, TX: StataCorp LP).  We used the genhw command to calculate Minor 
Allele Frequency (MAF) and HWE tests, a nonparametric test for trend for plasma ascorbate 
by genotype or a Kruskal-Wallis test for a 2 sample non-parametric comparison. We checked 
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that rs33972313 was not confounded by covariates shown in our study to be associated with 
plasma ascorbate.
4
 We used logistic regression to examine the associations with type of 
cataract and report adjusted (age, sex, centre) Odds Ratios and 95% Confidence Intervals. In 
sensitivity analyses we investigated (i) associations for pure cataract type (i.e. excluding 
mixed cataracts) (ii) the lens opacity score for each type of opacity using a standardized z-
score transformation in linear regression. Analyses of the lens opacity score used the score in 
the worst eye for participants with two eyes and scores from one eye for participants with 
unilateral aphakia/pseudophakia.  Differences in effect by centre were tested using an 
interaction term in the regression models. Analyses took account of the sampling design by 
use of robust standard errors and design-adjusted Wald tests. We used a Bonferroni-adjusted 
critical value of 0.025 for rs6596473 as this was a secondary hypothesis.  
 
Results  
Of 7518 enumerated people, 5428 (72%)  were interviewed for socioeconomic and lifestyle 
factors, attended an eye examination  and were subsequently genotyped for rs3392713. The 
mean (SD) age of participants was 67.6 (6) years, 52% (2843) were women, 73% (3938) 
lived in rural areas, 62% (3362) were illiterate. A half, 52% (2833) used tobacco; <1% of 
women and 40% (1029) of men drank alcohol regularly. Overall 16% (887) were overweight 
or obese and 15% (806) had MUAC indicating moderate to severe malnutrition.  The 
distribution of plasma ascorbate was right-skewed; 30% of samples were classified as 2 
µmol/L, the lowest detection level of the lab, and a further 28% had concentrations less than 
11 µmol/; fewer than 20% had adequate values (> 28 µmol/L) (Supplementary Figure). 
Mixed or pure types of cataract were graded as nuclear (2404), cortical (494) or posterior 
subcapsular cataract (PSC) (1026); 1,462 had no significant cataract and no history of 
cataract surgery and 775 had bilateral aphakia/ pseudophakia. 
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HWE p values and MAFs for rs33972313 were 0.12 and 0.015 and, for rs6596473, 0.36 and 
0.449 respectively .In analyses with rs3392713 we combined AA (n=3) with GA (n=159) due 
to the small numbers with the AA genotype. There was no difference in median (interquartile 
range, IQR) ascorbate concentrations by rs33972313 genotype: GG 7.3 (2-21.4) compared to 
GA plus AA, 6.3 (2 -19.7), p =0.4. For rs6596473 the median per-genotype difference in 
ascorbate concentration was around 1 µmol/L, p <0.01. There was no association of 
rs33972313 with ascorbate-related covariates and potential confounders of the  association 
with cataract including socio-demographic and economic characteristics, clinical and 
environmental factors (Supplementary Table 2). In analyses of mixed cataracts, we found no 
association of rs3392713 with nuclear cataract and an association with cortical and posterior 
subscapular cataracts (Table 1). In sensitivity analyses, associations were found between 
rs3392713 and pure cortical cataracts OR= 2.29 (1.12, 4.65) p=0.023   and with the 
standardized cortical opacity score (Table 1).  Addition of plasma ascorbate or other 
covariates to the analyses did not change the results. No associations by genotype or additive 
associations were found between rs6596473 and any cataract outcomes or sensitivity analyses 
(Table 2). We checked whether our results were confounded by age- related macular 
degeneration (AMD).
12
  Results excluding  53 late AMD cases and 1240 early AMD cases 
were almost identical to results in Table 1; p values were slightly reduced due to the smaller 
numbers. The ORs (95% CIs) for the association of rs3392713 were: nuclear cataract, 1.38 
(0.77, 2.47), p=0.28; cortical cataract, 2.84 (1.45,5.63), p=0.003; PSC, 1.79 (0.95,3.35), 
p=0.07. 
 
Discussion 
We found an approximately two-fold association of rs33972313 with both mixed and pure 
cortical cataracts and with mixed PSC cataracts. The association with cortical cataract was 
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also found using the continuous cortical opacity score. rs33972313 in  exon 8 is a missense 
SLC23A1 variant  causing  a  valine-to-methionine substitution in SVCT1 and has  been 
shown experimentally to reduce ascorbate transport by 40-50%.
13 
The main function of 
SVCT1, expressed primarily in the small intestine, liver, kidney, is  absorption of dietary 
vitamin C and renal reabsorption of ascorbate in the circulating blood.
14
 SVCT1  therefore 
plays a key role in regulation of whole body ascorbate homeostasis. Of SLC23A1 
polymorphisms rs33972313 has been consistently shown to influence plasma ascorbate 
concentrations. 
7 8
 A meta-analysis of five studies, over 15,000 participants, in the UK 
reported lower ascorbate concentration (–5.98, 95% CI -8.23, -3.73) per A allele;  ascorbate 
levels were generally high, around 45 to 55 µmol/L in  four  studies and lower (30 µmol/L) in 
one study with a smaller  allele difference in ascorbate of 2.87 lower.
7
 In the Copenhagen 
General Population Study, the mean ascorbate levels in the GG and GA genotypes were 29 
and 26 µmol/L and 22 µmol/L in the four AA carriers.
8
 It is noticeable that in these European 
studies, the per-allele differences were smaller (around 3 µmol/L) in the two studies with 
mean ascorbate concentrations of 30 µmol/L compared to per-allele differences of 6 µmol/L 
in the four studies with higher mean ascorbate levels.  In our study we found smaller 
differences in ascorbate concentrations by genotype reflecting lower ascorbate 
concentrations.  Our results were limited by the high proportion (30%) with ascorbate 
concentrations at the limit of detection and our relatively small sample given the low MAF of 
rs33972313. For SLC23A1 variant rs6596473,  the UK meta-analysis reported per-allele 
mean differences of 3 µmol/L in the discovery study replicated with smaller differences of 
1µmol/L.
7
  We  found a similar per-allele difference in ascorbate concentrations but no 
associations between rs6596473 and any cataract outcomes.  
In our study rs33972313 was not associated with other determinants of ascorbate, consistent 
with previous studies.
7 8
 These properties of rs33972313 - large per-allele effects on 
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ascorbate, lack of confounding and pleiotropy -  account for its choice as a key SNP for 
Mendelian Randomization (MR) analyses of ascorbate related outcomes. 
8 15 16
 
 
Study strengths and limitations 
We used an established cataract grading scale, LOCS III 
11
 and chose cut points to categorize 
type of cataract similar to other studies (reviewed in our cataract prevalence paper).
10
 The 
validity of our cataract definition for genetic studies is supported by other results from the 
INDEYE study, for example, an association of EPHA2 variants with cortical but not nuclear 
cataract 
17
 in agreement with results from other studies.
18
 Our sensitivity analysis showed that 
the findings for rs33972313 and cortical cataract were robust to different cataract measures. 
Our study was based on a random population sample with an over 70% response. However, 
our study was relatively small given the low MAF of rs33972313 (0.015). While the 
rs6596473 MAF was larger (0.45), the small per-allele influence of this SNP on ascorbate 
suggests larger studies than ours would be required.  
We had only a single measurement of plasma ascorbate taken in later life.  We found that 
adjustment for plasma ascorbate did not attenuate the association with rs33972313 possibly 
reflecting measurement error in ascorbate and that current concentrations may not reflect 
ascorbate concentrations at earlier life stages. Plasma vitamin C levels in our study were low. 
The few studies that have measured plasma vitamin C levels in India, including our previous 
studies
3 9
 also reported low levels.
19 20
    
 
SVCT1 has not been found to be expressed in ocular tissues
21
  or expressed only weakly in 
human lens epithelial tissues.
22
  SVCT2  is expressed in nearly all cell types including  the 
ciliary
22
, corneal 
21 23
 and lens epithelium.
22 24
 We originally aimed to investigate the  SVCT2 
variant (SLC23A2,  rs12479919 )  but  this was not possible because of genotyping errors. 
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While findings for rs12479919  and cataract risk  would undoubtably provide additional 
information on the role of genetic variation in SVCT transporters, we do not consider that the 
lack of this information limits the results we report for SLC23A1 variant rs33972313. Unlike 
most variants in SLC23A1 or SLC23A2  the  molecular consequences of  rs33972313, 
encoding an amino acid change in the SVCT1 protein, are known. We hypothesized that 
individuals carrying the risk allele of this variant would have a higher risk of cataract due to 
genetically lower plasma ascorbate.   Full understanding of the influences and mechanisms 
for upregulation and transport of plasma ascorbate  in human eyes is lacking. 22 Many studies 
have used rodent or rabbit tissues and findings may not  apply to humans.  Ma et al recently 
showed expression of SVCT2 varied between mouse and human ocular tissues.
22
  The 
authors found SVCT2 to be highly expressed in human ciliary pigmented epithelium located  
near the ciliary stromal microvasculature 
22
 a finding consistent with upregulation of 
ascorbate achieving molar concentrations in the aqueous. The concentration of ascorbate in 
the blood is a very strong predictor of the level in the aqueous,  as demonstrated by two 
studies, one in the US 
25
 and our study in India.
9
 Both studies showed log- linear associations 
of plasma ascorbate with aqueous ascorbate. We also found genotype differences in  aqueous  
ascorbate for SLC23A1 rs6596473 and  in  lens nucleus ascorbate with SLC23A2 rs12479919.  
In these analyses, plasma ascorbate was the strongest influence on concentrations of  aqueous 
and lens ascorbate. Genotype differences in plasma ascorbate were also found  for  both 
SLC23A1 and SLC23A2 variants suggesting that SLC23A2 may influence plasma ascorbate in 
tissues outside the eye. The only other published results on a SLC23A2 variant (rs1279386) in 
an eye condition also found a genotype difference in plasma ascorbate and that  rs1279386 
and plasma ascorbate were associated with an increased risk of primary open glaucoma. 
26 27
  
The authors concluded that the association of rs1279386 with glaucoma was directly 
mediated through plasma ascorbate.   
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The plausibility of our findings relates to the importance of ascorbate in lens protection, 
especially against the damaging effects of Ultraviolet Radiation B (UVB) and oxygen.
1 28
. 
Ascorbate plays a complex role including absorption of UVB, maintenance of the powerful 
antioxidant glutathione, oxygen reduction, scavenging and quenching of free radicals. The 
outer epithelial and cortical cells are most exposed to  UVB radiation and evidence from 
epidemiological studies that UVB is a risk factor for cataract is strongest for cortical 
cataracts.
29
  
In conclusion, using a robust genetic variant as a proxy for lifetime ascorbate concentrations, 
our results support a causal association between ascorbate and cortical cataract. Our study 
took place in the Indian setting with low concentrations of plasma ascorbate and it is 
uncertain whether our results would apply to other populations with adequate dietary vitamin 
C intakes and plasma ascorbate concentrations.  
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Supplementary Figure Legend 
Plasma ascorbate distribution (µmol/L) in the India age-related Eye Disease population study 
(INDEYE) 
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Table 1 Association of rs33972313 with types of cataract (i) mixed cataracts (ii) pure cataracts (iii) lens opacity scores in the two centre 
India age-related Eye Disease population study (INDEYE)  
 
Mixed cataracts
a,b
 Any Nuclear Any Cortical Any Posterior 
Subcapsular  
 OR (95% CI)
 c
 OR (95% CI)
 c
 OR (95% CI)
 c
 
    
Cases (n) 2295  494  1026  
Case genotype (n)  73 GA/AA, 2222 GG 20 GA/AA, 474 GG 37 GA/AA, 989 GG 
AA and GA vs GG 1.27 (0.83,1.95)  2.16 (1.34,3.49)  1.68 (1.06,2.65)  
p effect 0.279 0.002 0.03 
p difference by centre
 
0.789 0.569 0.676 
    
Pure cataracts
d,b 
Pure Nuclear Pure Cortical Pure Posterior 
Subcapsular 
 OR (95% CI)
c
 OR (95% CI)
c
 OR (95% CI)
c
 
Cases (n) 1429 192 222 
Case genotype (n)  41 GA/AA, 1388 GG 9 GA/AA, 183 GG 6 GA/AA, 216 GG 
AA and GA vs GG 1.11 (0.69,1.80)  2.29 (1.12,4.65)  1.19, (0.56, 2.52) 
p effect 0.671 0.023 0.653 
P difference by centre 0.672 0.995 0.712 
    
Opacity score
 
Nuclear score Cortical score Posterior Subcapsular 
score 
 Beta (95% CI)
 f 
Beta (95% CI)
f
 Beta (95% CI)
f
 
Participants (n) 4318 4336 4334 
Participants genotype 134 GA/AA, 4184 GG 134 GA/AA, 4202 GG 134 GA/AA, 4200 GG 
AA and GA vs GG 0.007 (-0.159, 0.173)  0.187 (0.005, 0.369)  0.103 (-0.080, 0.286)  
p effect 0.932 0.045 0.264 
p difference by centre 0.455 0.798 0.220 
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a 
any cataract type (pure or mixed) defined as Lens Opacity Classification System III grade: nuclear opacities ≥4, cortical opacities ≥3, posterior subcapsular opacities ≥2 
b
comparator group (controls) without cataract or operated cataract (i.e. <4 for nuclear opacities and <3 for cortical opacities and < 2for PSC, no dense opacities and no 
aphakia/pseudophakia) n=1462,40 GA/AA and 1422 GG 
c 
Odds ratio (OR), 95% Confidence Interval (CI) calculated from logistic regression adjusted for age, sex, study centre  
d 
pure cataract type defined as Lens Opacity Classification System III grade: nuclear opacities ≥4 cortical opacities ≥3, posterior subcapsular opacities ≥2, and no other type 
of opacity 
eStandardized scores of LOCS III nuclear opacity score in the worst eye graded in 0.1 units from 0.5 to 6.9, Cortical opacity score in the worst eye graded in 0.1 units from 0 
to 5.9, Posterior capsular opacity score in the worst eye graded in 0.1 units from 0 to 5.9  
f 
Beta coefficient (Beta), 95% Confidence Interval (CI) from regression analysis adjusted for age, sex, study center  
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Table 2 Association of rs6596473 with types of cataract (i) mixed cataracts (ii) pure cataracts (iii) lens opacity scores in the two centre 
India age-related Eye Disease population study (INDEYE)  
 
Mixed cataracts
a,b
 Any Nuclear Any Cortical Any Posterior 
Subcapsular  
 OR (95% CI)
 c
 OR (95% CI)
 c
 OR (95% CI)
 c
 
Cases (n) 2288  491  1026  
Additive association 1.05 (0.97,1.15)  1.02 (0.86,1.22)  1.05 (0.93, 1.19)  
p effect 0.220 0.789 0.406 
p difference by centre 0.826 0.782 0.918 
    
Pure cataracts
d,b 
Pure Nuclear Pure Cortical Pure Posterior 
Subcapsular 
 OR (95% CI)
c
 OR (95% CI)
c
 OR (95% CI)
c
 
Cases (n) 1421 187 218 
Additive association 1.05 (0.95,1.17)  0.97 (0.76,1.24)  0.99 (0.78, 1.27)  
p effect 0.304 0.825 0.966 
P difference by centre 0.904 0.564 0.821 
 
   
Opacity scores
e 
Nuclear score Cortical score Posterior Subcapsular 
score 
 Beta (95% CI)
f 
Beta (95% CI)
f
 Beta (95% CI)
f
 
Participants (n) 4292 4310 4308 
Per allele association 0.030 (-0.006, 0.065) -0.018 (-0.054, 0.019)  0.021 (-0.022, 0.063)  
p effect 0.103 0.339 0.338 
p difference by centre
6
 0.683 0.181 0.761 
 
a 
any cataract type (pure or mixed) defined as Lens Opacity Classification System III grade: nuclear opacities ≥4, cortical opacities ≥3, posterior subcapsular opacities ≥2 
b
comparator group (controls) without cataract or operated cataract (i.e. <4 for nuclear opacities and <3 for cortical opacities and < 2for PSC, no dense opacities and no 
aphakia/pseudophakia) n=1462 
c Odds ratio (OR), 95% Confidence Interval (CI) calculated from logistic regression adjusted for age, sex, study centre  
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d 
pure cataract type defined as Lens Opacity Classification System III grade: nuclear opacities ≥4 cortical opacities ≥3, posterior subcapsular opacities ≥2, and no other type 
of opacity 
e
Standardized scores of :LOCS III nuclear opacity score in the worst eye graded in 0.1 units from 0.5 to 6.9, Cortical opacity score in the worst eye graded in 0.1 units from 0 
to 5.9, Posterior capsular opacity score  in the worst eye graded in 0.1 units from 0 to 5.9  
f
Beta coefficient (Beta), 95% Confidence Interval (CI) from regression analysis adjusted for age, sex, study centre  
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Supplementary Table 1.  SLC23A1/2 Single Nucleotide Polymorphisms, Location, Alleles, Molecular consequences, Minor 
Allele Frequencies (MAFs) and Hardy Weinberg Equilibrium tests for participants in the India age-related Eye Disease 
population study (INDEYE) with corresponding reported MAFs in the 1000 genomes project in South Asian and European 
populations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Single Nucleotide Polymorphism  
2 p value for departure from Hardy Weinberg Equilibrium (HWE)  
3 Minor Allele Frequency (MAF) INDEYE Study 
4 Minor Allele Frequency (MAF from 1000 genome study for South Asian ancestry available in https://www.ncbi.nlm.nih.gov/snp accessed 14 June 2018 
5 Minor Allele Frequency (MAF) from 1000 genome study for European ancestry available in https://www.ncbi.nlm.nih.gov/snp accessed 14 June 2018 
SNP1 Location Major/Minor  
Allele 
Molecular consequences HWE2 MAF3 
 
MAF 
SAS4 
MAF 
EUR5 
SLC23A1 
Chromosome 5 
 
       
rs33972313 139.379.813 
 
G/A Exon 8 
Missense variant.  
0.1214 0.0150 0.0143 0.0348 
rs4257763 139.378.470 
 
G/A Intron  0.3296 0.4754 0.4990 0.6262 
rs6596473 139.374.887 G/C Intron  0.3630 0.4488 0.4775 0.3410 
rs10063949 139.383.837 T/C Intron  
2KB upstream variant  
0.3994 0.4611 0.4826 0.3817 
SLC23A2  
Chromosome 20 
 
       
rs12479919 5.000.094 C/T Intron  0.004 0.2826 0.2894 0.3658 
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Supplementary Table 2.  Characteristics of participants in the India age-related 
Eye Disease population study (INDEYE) by SLC23A1 SNP rs33972313  
 
1 157 participants with GA genotype and 3 participants with AA genotype. 
 2 p-value for difference between genotype (GG versus GA plus AA) calculated from Design-based 
Pearson Chi- squared test for categorical variables and Design adjusted Wald test for continuous 
variables. 
3 lowest quintile of the socio-economic score derived using principal component analysis (based on 
caste, landholding, roof type, number of rooms) and categorized by quintiles.  
4 highest quartile of midday sun exposure calculated from questionnaire responses on time spent 
outdoors at different over job and life periods and categorized by quartiles.   
5 Moderate and severe malnutrition defined as mid-upper arm circumference (<22 in men and <20 in 
women).  
6 Diabetes defined as blood glucose ≥ 200 mg/dl 
Characteristics SLC23A1 SNP rs33972313  
   GG 
n=5268 
GA and AA1 
n=160 
p-value2 
Age, mean years (SD) 67.6 (6.5) 66.9 (5.8) 0.07 
Women, n (%) 2763 (52.5)  80 (50.0) 0.61 
Low Socioeconomic status3, n (%) 1184 (22.5) 31 (19.4) 0.36 
Ever use of tobacco, n (%) 3250 (61.7) 99 (61.9) 0.97 
Biomass fuel use, mean years (SD) 47.5 (13.3) 46.7 (14.3) 0.64 
High Sun exposure4 n (%) 1286 (24.4) 38 (23.8) 0.86 
Body Mass Index ≥25 kg/square metre, n (%) 856 (16.3) 31 (19.5) 0.30 
Moderate and severe malnutrition5, n (%) 790 (15.0) 16 (10.0) 0.07 
Diabetes6, n (%) 268 (5.1) 8 (5.0) 0.96 
Cholesterol (µmol/L) mean (SD) 
 
4.52 (1.06) 4.66 (0.96) 0.15 
Diastolic Blood pressure (mm/Hg), mean (SD) 
 
74.1 (13.3) 73.5 (14.7) 0.69 
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